Clinical Trial Update: Immunonutrition for Diabetic Foot Ulcers [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating immunonutrition for diabetic foot ulcers has been terminated, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot Ulcer
• Diabetic Peripheral Neuropathy

Drugs mentioned

• Immunonutrition

Snippet

Sponsor: Prisma Health-Midlands | Conditions: Diabetes Mellitus, Diabetic Peripheral Neuropathy | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2024-12-27